{
    "Trade/Device Name(s)": [
        "Immunalysis Benzoylecgonine Urine Enzyme Immunoassay",
        "Immunalysis Benzoylecgonine Urine Calibrators",
        "Immunalysis Benzoylecgonine Urine Control Set"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K150925",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113751"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "April 2, 2015",
    "Summary Letter Received Date": "April 6, 2015",
    "Submission Date": "June 26, 2015",
    "Regulation Number(s)": [
        "21CFR862.3250",
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system",
        "Clinical Toxicology Calibrator",
        "Clinical Toxicology Control Material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzoylecgonine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Benzoylecgonine Urine Enzyme Immunoassay, Calibrators, and Control Set for qualitative and semi-quantitative detection of benzoylecgonine in urine using automated clinical chemistry analyzers",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of benzoylecgonine in human urine with automated clinical chemistry analyzers for preliminary drug of abuse testing; calibrators and controls for use in calibration and monitoring of assay performance",
    "fda_folder": "Toxicology"
}